tradingkey.logo
tradingkey.logo
Pesquisar

NeuroOne Medical Technologies Corp

NMTC
Adicionar à lista de desejos
3.000USD
-0.040-1.32%
Fechamento 07/01, 16:00ETCotações atrasadas em 15 min
25.85MValor de mercado
PerdaP/L TTM

Mais detalhes de NeuroOne Medical Technologies Corp Empresa

NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.

Informações de NeuroOne Medical Technologies Corp

Código da empresaNMTC
Nome da EmpresaNeuroOne Medical Technologies Corp
Data de listagemNov 09, 2012
CEORosa (David A)
Número de funcionários17
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 09
Endereço7599 Anagram Dr
CidadeEDEN PRAIRIE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal55344-7399
Telefone19524261383
Sitehttps://nmtc1.com/
Código da empresaNMTC
Data de listagemNov 09, 2012
CEORosa (David A)

Executivos da empresa NeuroOne Medical Technologies Corp

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
33.11K
-15.23%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
24.17K
+28.92%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
22.32K
+31.31%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
15.43K
-0.98%
Mr. Ronald (Ron) Mcclurg
Mr. Ronald (Ron) Mcclurg
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Christopher R. Volker
Mr. Christopher R. Volker
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Emily Johns
Ms. Emily Johns
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Chris Donovan
Mr. Chris Donovan
Investor Relations
Investor Relations
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
33.11K
-15.23%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
24.17K
+28.92%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
22.32K
+31.31%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
15.43K
-0.98%

Perguntas frequentes

Quem são os cinco principais acionistas de NeuroOne Medical Technologies Corp?

Os cinco principais acionistas de NeuroOne Medical Technologies Corp são: Mr. David A. (Dave) Rosa

Quantas instituições possuem ações da NeuroOne Medical Technologies Corp (NMTC)?

Em 2026Q1, 58 instituições possuíam ações da NeuroOne Medical Technologies Corp, com valor de mercado aproximado de 2.36M, representando 28.07% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -230396.00.